Abstract
To clarify the origin of cell-free fetal DNA in maternal plasma, we analyzed bidirectional transfer of plasma DNA between fetus and mother. We analyzed maternal and fetal plasma DNA obtained from 15 pregnant women at the time of Cesarean section. The subjects were five patients with preeclampsia and 10 gestational-age-matched normal controls. DNA was extracted from 1.5-ml plasma samples and the cellular fraction of maternal and umbilical blood. Seven polymorphic marker genes were analyzed. The relative concentration of fetal DNA in maternal plasma and maternal DNA in cord blood were evaluated. The relative concentration of maternal DNA in fetal circulation (median, 0.9%; range, 0.2–8.4%) was significantly lower than that of fetal DNA in maternal blood (14.3%, 2.3–64%), with P=0.007. The relative concentration of maternal DNA in fetal blood was not affected by preeclampsia. These findings indicate that cell-free DNA is unequally transferred through the placenta. The structural characteristics of the placenta suggest that the majority of cell-free fetal DNA in maternal plasma is derived from villous trophoblasts.
Similar content being viewed by others
References
Al-Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH (2000) Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 15:218–221
Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW (2003) Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. Clin Chem 49:195–198
Bauer M, Orescovic I, Schoell WM, Bianchi DW, Pertl B (2002) Detection of maternal deoxyribonucleic acid in umbilical cord plasma by using fluorescent polymerase chain reaction amplification of short tandem repeat sequences. Am J Obstet Gynecol 186:117–120
Bianchi DW (1995) Prenatal diagnosis by analysis of fetal cells in maternal blood. J Pediatr 127:847–856
Hoesli I, Danek M, Lin D, Li Y, Hahn S, Holzgreve W (2002) Circulating erythroblasts in maternal blood are not elevated before onset of preterm labor. Obstet Gynecol 100:992–996
Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186:158–166
Kasai K, Nakamura Y, White R (1990) Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J Forensic Sci 35:1196–1200
Kondo T, Sekizawa A, Saito H, Jimbo M, Sugito Y, Okai T (2002) Fate of fetal nucleated erythrocytes circulating in maternal blood: apoptosis is induced by maternal oxygen concentration. Clin Chem 48:1618–1620
Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM (1998) Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352:1904–1905
Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS (1996) Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 88:4390–4395
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487
Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS (1998a) Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734–1738
Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM (1998b) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62:768–775
Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45:184–188
Lo YM, Lau TK, Chan LY, Leung TN, Chang AM (2000) Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46:1301–1309
Loke Y, King A (1997) Immunology of human placental implantation: clinical implications of our current understanding. Mol Med Today 3:153–159
Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW (1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351:559–562
Pertl B, Sekizawa A, Samura O, Orescovic I, Rahaim PT, Bianchi DW (2000) Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet 106:45–49
Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356:1170
Sekizawa A, Samura O, Zhen DK, Falco V, Farina A, Bianchi DW (2000) Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 20:886–889
Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, Okai T (2001) Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 47:1856–1858
Sekizawa A, Jimbo M, Saito H, Iwasaki M, Sugito Y, Yukimoto Y, Otsuka J, Okai T (2002) Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 48:353–354
Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, Farina A (2003) Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 188:480–484
Acknowledgements
This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sport and Culture of Japan (nos. 14770870 and 13770940).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sekizawa, A., Yokokawa, K., Sugito, Y. et al. Evaluation of bidirectional transfer of plasma DNA through placenta. Hum Genet 113, 307–310 (2003). https://doi.org/10.1007/s00439-003-0987-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-003-0987-4